Press Releases

Official press releases

TB2016 highlights efforts to strengthen the global fight against tuberculosis, the leading killer of people with HIV, at the 21st International AIDS Conference (AIDS 2016)

posted on

For release
Saturday, 16 July 2016
13:30 SAST

Durban, South Africa – Urgency in efforts to address the devastating global impact of tuberculosis (TB), and opportunities to make major inroads against the infectious disease, are being featured at TB2016, a two-day conference dedicated exclusively to TB, immediately preceding AIDS 2016 in Durban, South Africa. Organised by the International AIDS Society (IAS), which also leads the AIDS 2016 conference, TB2016 represents a unique partnership of HIV and TB scientists and advocates, convened to build greater urgency and innovation to combat both epidemics.

TB2016 will bring political leaders, advocates, health workers, and scientists together to address the policy, scientific, and advocacy components of efforts to expand and speed the global TB response. This inaugural TB pre-conference at the international AIDS meeting will bring together global experts to advance knowledge and innovation on TB, promote and share best practices to reinvigorate the global TB response, and galvanize political leadership and commitment to end TB by 2035.

Although it is one of the world’s oldest disease, TB is not currently on the decline. In fact, a recent World Health Organization (WHO) report found that the global TB epidemic is even larger than previously thought, revising the estimated global burden of TB upward for the second year in a row. The millennia-old disease sickened almost 10 million people last year and claimed 1.5 million lives, despite being preventable, treatable and curable. People living with HIV are particularly susceptible to TB infection and to TB-related illness. 
“We cannot win the fight against AIDS without also tackling TB,” said Linda-Gail Bekker, IAS President-Elect. “Too often, TB and HIV team up against us, but with this conference we are supporting a global movement to bring the TB and HIV responses together to defeat both epidemics. TB 2016 reminds us that the work before us will take place not only in laboratories, but also in the halls government, in health facilities, and in the communities affected by these two devastating epidemics.”
Commenting on the rapidly evolving science of TB prevention and treatment, Valerie Mizrahi, Head of the University of Cape Town's Institute of Infectious Disease and Molecular Medicine, added, “The TB 2016 program highlights the urgency of using the treatments and public health interventions we have today, as well as the need for new tools and approaches to tackle TB, drug-resistant TB, and the complex co-epidemic of TB and HIV. Recent scientific advances and a new global plan to end TB point to opportunities ahead. But the challenges of a vastly under-resourced response, a lack of political urgency, and the growing threat of drug resistance must all be confronted head on if we are to reduce the global burden of TB.”  
“TB is preventable, treatable, and curable, yet we have allowed it to become the world’s leading infectious killer, and the leading killer of people with HIV,” said Joanne Carter, RESULTS. “The question is not whether we are able to do more, but rather whether we will make the fight against TB a global public health priority it must become. TB2016 is an important step forward in the effort to bring the needed scientific, financial, and political resources to bear against this global killer.”
At TB2016, parliamentarians from 20 African countries will launch the African TB Parliamentarians Caucus. The caucus is committed to pressing for increased domestic investment in TB care and prevention, with a particular focus on the twin epidemics of TB and HIV. This regional group is part of the growing Global TB Caucus, a team of parliamentarians and other political leaders from more than 120 countries worldwide.
For more information visit:
About the International AIDS Society (IAS)
Founded in 1988, the International AIDS Society (IAS) is the world’s largest association of HIV professionals, with members from more than 180 countries. IAS members work on all fronts of the global response to AIDS and include researchers, clinicians, policy and programme planners, and public health and community practitioners. 
About the International AIDS Conference (AIDS 2016)
The International AIDS Conference is the largest conference on any global health or development issue in the world. First convened during the peak of the AIDS epidemic in 1985, it continues to provide a unique forum for the intersection of science, advocacy, and human rights. Each conference is an opportunity to strengthen policies and programmes that ensure an evidence-based response to the epidemic. The next International AIDS Conference (AIDS 2016) will be held in Durban, South Africa from 16-22 July 2016.
Media Contact:
Maria Djordjevic
 +27 82 334 6192 (South Africa)
[email protected]

| Return

Third party press releases

Collaborative Canadian study on HIV, housing and health wins 2016 Robert Carr Research Award
27 July 2016

Ten organizations receive Red Ribbon Award for outstanding community leadership on AIDS
27 July 2016

Founding Patron, Prince Harry, and Sir Elton John speak out about empowering youth at the International AIDS Conference in Durban
21 July 2016

LetsStopAIDS Celebrates 10 Years of Youth-HIV programming in KwaZulu-Natal
Additional info
21 July 2016

India Endangering the Global AIDS Response: Constitutional Court Justice, Human Rights Activists, and Medical Groups Raise Alarm
21 July 2016

Elton John AIDS Foundation and PEPFAR Announce Inaugural LGBT Fund Recipients
20 July 2016

Fast-Track Cities Unveil 90-90-90 and HIV Care Continuum Data at AIDS 2016 Demonstrating Progress Towards Goal of Ending AIDS as a Public Health Threat by 2030
20 July 2016

A Conversation with Amb. Birx & Minister Motsoaledi in Durban
20 July 2016

The Lancet: Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis
19 July 2016

The Lancet: Criminal justice reforms could reduce national HIV and tuberculosis burdens in sub-Saharan Africa
19 July 2016

Update on investigational prime boost HIV-1 vaccine regimen in development at the Janssen Pharmaceutical Companies of Johnson & Johnson
19 July 2016

Johnson & Johnson press availability: HIV prevention efforts and update on global public health Africa operations
19 July 2016

Unprecedented Funding Drop Threatens Global AIDS Response Experts Warn of Significant Epidemiological Impact
19 July 2016

ONE issues warning to African leaders attending IAC: Step up fight against HIV and AIDS or risk millions of lives
18 July 2016

United Nations Secretary-General Ban Ki-moon invokes the memory of Madiba and calls for Universal Access to Medicines at International Aids Conference
18 July 2016

PEPFAR and DREAMS Partners Announce Winners of the $85 Million DREAMS Innovation Challenge
18 July 2016

PEPFAR Welcomes the Return of the International HIV/AIDS Conference to Africa
18 July 2016

mothers2mothers Announces Reduction of Mother-to-Child Transmission of HIV to 2.1% among Programme Participants: Peer Mentor Approach Effective and Transferable Across Health Issues
18 July 2016

ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Women Living with HIV
18 July 2016

United Nations Secretary-General Ban Ki-moon to discuss the High-Level Panel on Access to Medicines
16 July 2016

EJAF Founder Elton John and Prince Harry to Host Special Session at 2016 International AIDS Conference
14 July 2016

Sentebale’s founding patron, Prince Harry heads to Durban to talk at the International AIDS Conference
14 July 2016